Prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft.
<h4>Background</h4>A variety of surgical procedures are now available for tissue reconstruction after osteosarcoma excision, and an important prognostic factor is the evaluation of response to chemotherapy using histology. Although tumor-bearing autografts are useful tools for reconstruc...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3272db1bb23247d586c1dcb748b76fa1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3272db1bb23247d586c1dcb748b76fa1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3272db1bb23247d586c1dcb748b76fa12021-11-18T08:59:26ZPrognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft.1932-620310.1371/journal.pone.0071362https://doaj.org/article/3272db1bb23247d586c1dcb748b76fa12013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23977028/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>A variety of surgical procedures are now available for tissue reconstruction after osteosarcoma excision, and an important prognostic factor is the evaluation of response to chemotherapy using histology. Although tumor-bearing autografts are useful tools for reconstruction, re-use of the primary tumor may make it difficult to assess the histological response to chemotherapy, since the entire tumor cannot be analyzed. Here, we analyzed the prognostic value of the histological response in the patients who received frozen tumor-bearing autografts for reconstruction.<h4>Method</h4>Retrospective analysis of the medical records of 51 patients with high-grade osteosarcoma of the extremities was performed. All patients received reconstruction using frozen tumor-bearing autografts. Tumor necrosis was evaluated in extraskeletal masses and cancellous bone.<h4>Results</h4>Five-year overall survival of patients with good and poor response to chemotherapy was 82.9% and 46.4%, respectively (P = 0.044), and 5-year event-free survival was 57.7% and 36.0%, respectively (P = 0.329). Multivariate analysis revealed that a poor histological response to chemotherapy was a significant prognostic factor for overall survival (P = 0.033).<h4>Conclusion</h4>Histological response is an important and reliable prognostic factor in patients undergoing reconstruction using frozen tumor-bearing autografts.Shinji MiwaAkihiko TakeuchiHiroko IkedaToshiharu ShiraiNorio YamamotoHideji NishidaKatsuhiro HayashiYoshikazu TanzawaHiroaki KimuraKentaro IgarashiHiroyuki TsuchiyaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 8, p e71362 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Shinji Miwa Akihiko Takeuchi Hiroko Ikeda Toshiharu Shirai Norio Yamamoto Hideji Nishida Katsuhiro Hayashi Yoshikazu Tanzawa Hiroaki Kimura Kentaro Igarashi Hiroyuki Tsuchiya Prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft. |
description |
<h4>Background</h4>A variety of surgical procedures are now available for tissue reconstruction after osteosarcoma excision, and an important prognostic factor is the evaluation of response to chemotherapy using histology. Although tumor-bearing autografts are useful tools for reconstruction, re-use of the primary tumor may make it difficult to assess the histological response to chemotherapy, since the entire tumor cannot be analyzed. Here, we analyzed the prognostic value of the histological response in the patients who received frozen tumor-bearing autografts for reconstruction.<h4>Method</h4>Retrospective analysis of the medical records of 51 patients with high-grade osteosarcoma of the extremities was performed. All patients received reconstruction using frozen tumor-bearing autografts. Tumor necrosis was evaluated in extraskeletal masses and cancellous bone.<h4>Results</h4>Five-year overall survival of patients with good and poor response to chemotherapy was 82.9% and 46.4%, respectively (P = 0.044), and 5-year event-free survival was 57.7% and 36.0%, respectively (P = 0.329). Multivariate analysis revealed that a poor histological response to chemotherapy was a significant prognostic factor for overall survival (P = 0.033).<h4>Conclusion</h4>Histological response is an important and reliable prognostic factor in patients undergoing reconstruction using frozen tumor-bearing autografts. |
format |
article |
author |
Shinji Miwa Akihiko Takeuchi Hiroko Ikeda Toshiharu Shirai Norio Yamamoto Hideji Nishida Katsuhiro Hayashi Yoshikazu Tanzawa Hiroaki Kimura Kentaro Igarashi Hiroyuki Tsuchiya |
author_facet |
Shinji Miwa Akihiko Takeuchi Hiroko Ikeda Toshiharu Shirai Norio Yamamoto Hideji Nishida Katsuhiro Hayashi Yoshikazu Tanzawa Hiroaki Kimura Kentaro Igarashi Hiroyuki Tsuchiya |
author_sort |
Shinji Miwa |
title |
Prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft. |
title_short |
Prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft. |
title_full |
Prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft. |
title_fullStr |
Prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft. |
title_full_unstemmed |
Prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft. |
title_sort |
prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/3272db1bb23247d586c1dcb748b76fa1 |
work_keys_str_mv |
AT shinjimiwa prognosticvalueofhistologicalresponsetochemotherapyinosteosarcomapatientsreceivingtumorbearingfrozenautograft AT akihikotakeuchi prognosticvalueofhistologicalresponsetochemotherapyinosteosarcomapatientsreceivingtumorbearingfrozenautograft AT hirokoikeda prognosticvalueofhistologicalresponsetochemotherapyinosteosarcomapatientsreceivingtumorbearingfrozenautograft AT toshiharushirai prognosticvalueofhistologicalresponsetochemotherapyinosteosarcomapatientsreceivingtumorbearingfrozenautograft AT norioyamamoto prognosticvalueofhistologicalresponsetochemotherapyinosteosarcomapatientsreceivingtumorbearingfrozenautograft AT hidejinishida prognosticvalueofhistologicalresponsetochemotherapyinosteosarcomapatientsreceivingtumorbearingfrozenautograft AT katsuhirohayashi prognosticvalueofhistologicalresponsetochemotherapyinosteosarcomapatientsreceivingtumorbearingfrozenautograft AT yoshikazutanzawa prognosticvalueofhistologicalresponsetochemotherapyinosteosarcomapatientsreceivingtumorbearingfrozenautograft AT hiroakikimura prognosticvalueofhistologicalresponsetochemotherapyinosteosarcomapatientsreceivingtumorbearingfrozenautograft AT kentaroigarashi prognosticvalueofhistologicalresponsetochemotherapyinosteosarcomapatientsreceivingtumorbearingfrozenautograft AT hiroyukitsuchiya prognosticvalueofhistologicalresponsetochemotherapyinosteosarcomapatientsreceivingtumorbearingfrozenautograft |
_version_ |
1718421072853860352 |